Cardiovascular disease risk reduction with sleep apnea treatment

References

• National Commission on Sleep Disorders Research. The National Commission on Sleep Disorders Research. Wake up America: a national sleep alert. US Government Printing Office, Washington DC, USA (2008).
   Google Scholar
• Shahar E, Whitney CW, Redline S et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am. J. Respir. Crit. Care Med.163(1), 19–25 (2001).
   PubMed Web of Science ®Google Scholar
• Mehra R, Benjamin EJ, Shahar E et al. Association of nocturnal arrhythmias with sleep-disordered breathing: the Sleep Heart Health Study. Am. J. Respir. Crit. Care Med.173(8), 910–916 (2006).
   PubMed Web of Science ®Google Scholar
• Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea–hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet365(9464), 1046–1053 (2005).
   PubMed Web of Science ®Google Scholar
• Hung J, Whitford EG, Parsons RW, Hillman DR. Association of sleep apnoea with myocardial infarction in men. Lancet336(8710), 261–264 (1990).
   PubMed Web of Science ®Google Scholar
• Valham F, Mooe T, Rabben T, Stenlund H, Wiklund U, Franklin KA. Increased risk of stroke in patients with coronary artery disease and sleep apnea: a 10-year follow-up. Circulation118(9), 955–960 (2008).
   PubMed Web of Science ®Google Scholar
• Somers VK, White DP, Amin R et al. Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. J. Am. Coll. Cardiol.52(8), 686–717 (2008).
   PubMed Web of Science ®Google Scholar
• Coccagna G, Mantovani M, Brignani F, Parchi C, Lugaresi E. Tracheostomy in hypersomnia with periodic breathing. Bull. Physiopathol. Respir. (Nancy)8(5), 1217–1227 (1972).
   PubMedGoogle Scholar
• Coccagna G, Mantovani M, Brignani F, Parchi C, Lugaresi E. Continuous recording of the pulmonary and systemic arterial pressure during sleep in syndromes of hypersomnia with periodic breathing. Bull. Physiopathol. Respir.(Nancy)8(5), 1159–1172 (1972).
   PubMedGoogle Scholar
• Stoohs RA, Guilleminault C, Itoi A, Dement WC. Traffic accidents in commercial long-haul truck drivers: the influence of sleep-disordered breathing and obesity. Sleep17(7), 619–623 (1994).
   PubMed Web of Science ®Google Scholar
• El Ad B, Lavie P. Effect of sleep apnea on cognition and mood. Int. Rev. Psychiatry17(4), 277–282 (2005).
   PubMed Web of Science ®Google Scholar
• Sharafkhaneh A, Giray N, Richardson P, Young T, Hirshkowitz M. Association of psychiatric disorders and sleep apnea in a large cohort. Sleep28(11), 1405–1411 (2005).
   PubMed Web of Science ®Google Scholar
• Punjabi NM, Caffo BS, Goodwin JL et al. Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med.6(8), e1000132 (2009).
   PubMed Web of Science ®Google Scholar
• Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. N. Engl. J. Med.353(19), 2034–2041 (2005).
   PubMed Web of Science ®Google Scholar
• Aartz M, Young T, Finn L, Skatrud JB, Bradley D. Association of sleep-disordered breathing and the occurence of stroke. Am. J. Respir. Crit. Care Med.172, 1447–1451 (2005).
   PubMed Web of Science ®Google Scholar
• Lavie P, Lavie L, Herer P. All-cause mortality in males with sleep apnoea syndrome: declining mortality rates with age. Eur. Respir. J.25(3), 514–520 (2005).
   PubMed Web of Science ®Google Scholar
• Gami AS, Pressman G, Caples SM. Association of atrial fibrillation and obstructive sleep apnea. Circulation27(364), 364–367 (2004).
   Google Scholar
• Kiely JL, McNicholas WT, Zgierska A et al. Cardiovascular risk factors in patients with obstructive sleep apnoea syndrome. Eur. Respir. J.16(1), 128–133 (2000).
   PubMed Web of Science ®Google Scholar
• Bradley TD, Floras JS. Obstructive sleep apnoea and its cardiovascular consequences. Lancet373(9657), 82–93 (2009).
   PubMed Web of Science ®Google Scholar
• Shepard JW Jr, Garrison MW, Grither DA, Evans R, Schweitzer PK. Relationship of ventricular ectopy to nocturnal oxygen desaturation in patients with chronic obstructive pulmonary disease. Am. J. Med.78(1), 28–34 (1985).
   PubMed Web of Science ®Google Scholar
• Shamsuzzaman AS, Gersh BJ, Somers VK. Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA290(14), 1906–1914 (2003).
   PubMed Web of Science ®Google Scholar
• Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J. Clin. Invest96(4), 1897–1904 (1995).
   PubMed Web of Science ®Google Scholar
• Dyken ME, Somers VK, Yamada T, Ren ZY, Zimmerman MB. Investigating the relationship between stroke and obstructive sleep apnea. Stroke27(3), 401–407 (1996).
   PubMed Web of Science ®Google Scholar
• Sanner BM, Konermann M, Tepel M, Groetz J, Mummenhoff C, Zidek W. Platelet function in patients with obstructive sleep apnoea syndrome. Eur. Respir. J.16(4), 648–652 (2000).
   PubMed Web of Science ®Google Scholar
• Franklin KA, Nilsson JB, Sahlin C, Naslund U. Sleep apnoea and nocturnal angina. Lancet345(8957), 1085–1087 (1995).
   PubMed Web of Science ®Google Scholar
• Bradley TD. Right and left ventricular functional impairment and sleep apnea. Clin. Chest Med.13(3), 459–479 (1992).
   PubMed Web of Science ®Google Scholar
• Lavie L. Obstructive sleep apnoea syndrome – an oxidative stress disorder. Sleep Med. Rev.7(1), 35–51 (2003).
   PubMed Web of Science ®Google Scholar
• Kasasbeh E, Chi DS, Krishnaswamy G. Inflammatory aspects of sleep apnea and their cardiovascular consequences. South Med. J.99(1), 58–67 (2006).
   PubMed Web of Science ®Google Scholar
• Ip MS, Lam B, Chan LY et al. Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am. J. Respir. Crit. Care Med.162(6), 2166–2171 (2000).
   PubMed Web of Science ®Google Scholar
• von Kanel R, Loredo JS, Powell FL, Adler KA, Dimsdale JE. Short-term isocapnic hypoxia and coagulation activation in patients with sleep apnea. Clin. Hemorheol. Microcirc.33(4), 369–377 (2005).
   PubMed Web of Science ®Google Scholar
• Mills PJ, von Kanel R, Norman D, Natarajan L, Ziegler MG, Dimsdale JE. Inflammation and sleep in healthy individuals. Sleep30(6), 729–735 (2007).
   PubMed Web of Science ®Google Scholar
• Young T, Finn L. Epidemiological insights into the public health burden of sleep disordered breathing: sex differences in survival among sleep clinic patients. Thorax53(Suppl. 3), S16–S19 (1998).
   PubMed Web of Science ®Google Scholar
• Young T, Peppard P, Palta M et al. Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch. Intern. Med.157(15), 1746–1752 (1997).
   PubMed Web of Science ®Google Scholar
• Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N. Engl. J. Med.328(17), 1230–1235 (1993).
   PubMed Web of Science ®Google Scholar
• Remmers JE, Launois S, Feroah T, Whitelaw WA. Mechanics of the pharynx in patients with obstructive sleep apnea. Prog. Clin. Biol. Res.345, 261–268 (1990).
   PubMedGoogle Scholar
• Guilleminault C, Tilkian A, Dement WC. The sleep apnea syndromes. Annu. Rev. Med.27(465), 465–484 (1976).
   PubMed Web of Science ®Google Scholar
• Rechtshaffen A, Kales A. A manual of standardized terminology, techniques, and scoring systems of sleep stages of human subjects. UCLA Brain Information Service/Brain Research Institute, Los Angeles, USA (1968).
   Google Scholar
• Chesson AL Jr, Ferber RA, Fry JM et al. The indications for polysomnography and related procedures. Sleep20(6), 423–487 (1997).
   PubMed Web of Science ®Google Scholar
• Principles and Practice of Sleep Medicine. Kryger M, Roth T, Dement W (Eds). WB Saunders Co., PA, USA, 1–1336 (2002).
   Google Scholar
• Giles TL, Lasserson TJ, Smith BH, White J, Wright J, Cates CJ. Continuous positive airways pressure for obstructive sleep apnoea in adults. Cochrane Database Syst. Rev.3, CD001106 (2006).
   Google Scholar
• Stepnowsky CJ, Palau JJ, Gifford AL, Ancoli-Israel S. A self-management approach to improving continuous positive airway pressure adherence and outcomes. Behav. Sleep Med.5(2), 131–146 (2007).
   PubMedGoogle Scholar
• Strobel RJ, Rosen RC. Obesity and weight loss in obstructive sleep apnea: a critical review. Sleep19(2), 104–115 (1996).
   PubMed Web of Science ®Google Scholar
• Malone S, Liu PP, Holloway R, Rutherford R, Xie A, Bradley TD. Obstructive sleep apnoea in patients with dilated cardiomyopathy: effects of continuous positive airway pressure. Lancet338(8781), 1480–1484 (1991).
   PubMed Web of Science ®Google Scholar
• Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J. Clin. Invest.96(4), 1897–1904 (1995).
   PubMed Web of Science ®Google Scholar
• Buchner NJ, Sanner BM, Borgel J, Rump LC. Continuous positive airway pressure treatment of mild to moderate obstructive sleep apnea reduces cardiovascular risk. Am. J. Respir. Crit. Care Med.176(12), 1274–1280 (2007).
   PubMed Web of Science ®Google Scholar
• Doherty LS, Kiely JL, Swan V, McNicholas WT. Long-term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome. Chest127(6), 2076–2084 (2005).
   PubMed Web of Science ®Google Scholar
• Ohike Y, Kozaki K, Iijima K et al. Amelioration of vascular endothelial dysfunction in obstructive sleep apnea syndrome by nasal continuous positive airway pressure – possible involvement of nitric oxide and asymmetric NG, NG-dimethylarginine. Circ. J.69(2), 221–226 (2005).
   PubMed Web of Science ®Google Scholar
• Yokoe T, Minoguchi K, Matsuo H et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation107(8), 1129–1134 (2003).
   PubMed Web of Science ®Google Scholar
• Ryan S, Taylor CT, McNicholas WT. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation112(17), 2660–2667 (2005).
   PubMed Web of Science ®Google Scholar
• Dorkova Z, Petrasova D, Molcanyiova A, Popovnakova M, Tkacova R. Effects of continuous positive airway pressure on cardiovascular risk profile in patients with severe obstructive sleep apnea and metabolic syndrome. Chest134(4), 686–692 (2008).
   PubMed Web of Science ®Google Scholar
• Schulz R, Schmidt D, Blum A et al. Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy. Thorax55(12), 1046–1051 (2000).
   PubMed Web of Science ®Google Scholar
• Tasali E, Ip MS. Obstructive sleep apnea and metabolic syndrome: alterations in glucose metabolism and inflammation. Proc. Am. Thorac. Soc.5(2), 207–217 (2008).
   PubMedGoogle Scholar
• Vgontzas AN, Papanicolaou DA, Bixler EO et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J. Clin. Endocrinol. Metab.85(3), 1151–1158 (2000).
   PubMed Web of Science ®Google Scholar
• Ford ES. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care28(11), 2745–2749 (2005).
   PubMed Web of Science ®Google Scholar
• Alberti KG, Eckel RH, Grundy SM et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation120(16), 1640–1645 (2009).
   PubMed Web of Science ®Google Scholar
• Grundy SM. A constellation of complications: the metabolic syndrome. Clin. Cornerstone7(2–3), 36–45 (2005).
   PubMedGoogle Scholar
• Alexander CM. The coming of age of the metabolic syndrome. Diabetes Care26(11), 3180–3181 (2003).
   PubMed Web of Science ®Google Scholar
• Parish JM, Adam T, Facchiano L. Relationship of metabolic syndrome and obstructive sleep apnea. J. Clin. Sleep Med.3(5), 467–472 (2007).
   PubMed Web of Science ®Google Scholar
• Ambrosetti M, Lucioni AM, Conti S, Pedretti RF, Neri M. Metabolic syndrome in obstructive sleep apnea and related cardiovascular risk. J. Cardiovasc. Med. (Hagerstown)7(11), 826–829 (2006).
   PubMed Web of Science ®Google Scholar
• Drager LF, Bortolotto LA, Maki-Nunes C et al. The incremental role of obstructive sleep apnoea on markers of atherosclerosis in patients with metabolic syndrome. Atherosclerosis208(2), 490–495 (2010).
   PubMed Web of Science ®Google Scholar
• Oktay B, Akbal E, Firat H, Ardic S, Kizilgun M. CPAP treatment in the coexistence of obstructive sleep apnea syndrome and metabolic syndrome, results of one year follow up. Acta Clin. Belg.64(4), 329–334 (2009).
   PubMed Web of Science ®Google Scholar
• Grunstein R, Wilcox I, Yang TS, Gould Y, Hedner J. Snoring and sleep apnoea in men: association with central obesity and hypertension. Int. J. Obes. Relat. Metab. Disord.17(9), 533–540 (1993).
   PubMed Web of Science ®Google Scholar
• Kushida CA, Efron B, Guilleminault C. A predictive morphometric model for the obstructive sleep apnea syndrome. Ann. Intern. Med.127(8 Pt 1), 581–587 (1997).
   PubMed Web of Science ®Google Scholar
• Punjabi NM, Sorkin JD, Katzel LI, Goldberg AP, Schwartz AR, Smith PL. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am. J. Respir. Crit. Care Med.165(5), 677–682 (2002).
   PubMed Web of Science ®Google Scholar
• Peppard PE, Young T, Palta M, Dempsey J, Skatrud J. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA284(23), 3015–3021 (2000).
   PubMed Web of Science ®Google Scholar
• Dixon JB, Schachter LM, O’Brien PE. Polysomnography before and after weight loss in obese patients with severe sleep apnea. Int. J. Obes. (Lond.)29(9), 1048–1054 (2005).
   PubMed Web of Science ®Google Scholar
• Rao A, Tey BH, Ramalingam G, Poh AG. Obstructive sleep apnoea (OSA) patterns in bariatric surgical practice and response of OSA to weight loss after laparoscopic adjustable gastric banding (LAGB). Ann. Acad. Med. Singapore38(7), 587–587 (2009).
   PubMed Web of Science ®Google Scholar
• Cunneen SA. Review of meta-analytic comparisons of bariatric surgery with a focus on laparoscopic adjustable gastric banding. Surg. Obes. Relat Dis.4(3 Suppl.), S47–S55 (2008).
   PubMed Web of Science ®Google Scholar
• Redenius R, Murphy C, O’Neill E, Al Hamwi M, Zallek SN. Does CPAP lead to change in BMI? J. Clin. Sleep Med.4(3), 205–209 (2008).
   PubMed Web of Science ®Google Scholar
• Kajaste S, Brander PE, Telakivi T, Partinen M, Mustajoki P. A cognitive-behavioral weight reduction program in the treatment of obstructive sleep apnea syndrome with or without initial nasal CPAP: a randomized study. Sleep Med.5(2), 125–131 (2004).
   PubMed Web of Science ®Google Scholar
• Marcus DM, Lynn J, Miller JJ, Chaudhary O, Thomas D, Chaudhary B. Sleep disorders: a risk factor for pseudotumor cerebri? J. Neuroophthalmol.21(2), 121–123 (2001).
   PubMed Web of Science ®Google Scholar
• Lavie P, Herer P, Hoffstein V. Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. Br. Med. J.320(7233), 479–482 (2000).
   PubMed Web of Science ®Google Scholar
• Ohayon MM, Guilleminault C, Priest RG, Zulley J, Smirne S. Is sleep-disordered breathing an independent risk factor for hypertension in the general population (13,057 subjects)? J. Psychosom. Res.48(6), 593–601 (2000).
   PubMed Web of Science ®Google Scholar
• Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N. Engl. J. Med.342(19), 1378–1384 (2000).
   PubMed Web of Science ®Google Scholar
• Kaneko Y, Floras JS, Usui K et al. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N. Engl. J. Med.348(13), 1233–1241 (2003).
   PubMed Web of Science ®Google Scholar
• Mayer J, Becker H, Brandenburg U, Penzel T, Peter JH, von Wichert P. Blood pressure and sleep apnea: results of long-term nasal continuous positive airway pressure therapy. Cardiology79(2), 84–92 (1991).
   PubMed Web of Science ®Google Scholar
• Coughlin SR, Mawdsley L, Mugarza JA, Wilding JP, Calverley PM. Cardiovascular and metabolic effects of CPAP in obese males with OSA. Eur. Respir. J.29(4), 720–727 (2007).
   PubMed Web of Science ®Google Scholar
• Duran-Cantolla J, Aizpuru F, Martinez-Null C, Barbe-Illa F. Obstructive sleep apnea/hypopnea and systemic hypertension. Sleep Med. Rev.13(5), 323–331 (2009).
   PubMed Web of Science ®Google Scholar
• Alajmi M, Mulgrew AT, Fox J et al. Impact of continuous positive airway pressure therapy on blood pressure in patients with obstructive sleep apnea hypopnea: a meta-analysis of randomized controlled trials. Lung185(2), 67–72 (2007).
   PubMed Web of Science ®Google Scholar
• Harris MI. Diabetes in America: epidemiology and scope of the problem. Diabetes Care21(Suppl. 3), C11–C14 (1998).
   PubMed Web of Science ®Google Scholar
• Vgontzas AN, Bixler EO, Chrousos GP. Metabolic disturbances in obesity versus sleep apnoea: the importance of visceral obesity and insulin resistance. J. Intern.Med.254(1), 32–44 (2003).
   PubMed Web of Science ®Google Scholar
• Punjabi NM, Polotsky VY. Disorders of glucose metabolism in sleep apnea. J. Appl. Physiol.99(5), 1998–2007 (2005).
   PubMed Web of Science ®Google Scholar
• Punjabi NM, Ahmed MM, Polotsky VY, Beamer BA, O’Donnell CP. Sleep-disordered breathing, glucose intolerance, and insulin resistance. Respir. Physiol. Neurobiol.136(2–3), 167–178 (2003).
   PubMed Web of Science ®Google Scholar
• Punjabi NM, Shahar E, Redline S, Gottlieb DJ, Givelber R, Resnick HE. Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am. J. Epidemiol.160(6), 521–530 (2004).
   PubMed Web of Science ®Google Scholar
• Lam JC, Lam B, Yao TJ et al. A randomised controlled trial of nasal continuous positive airway pressure on insulin sensitivity in obstructive sleep apnoea. Eur. Respir. J.35(1), 138–145 (2010).
   PubMed Web of Science ®Google Scholar
• Dawson A, Abel SL, Loving RT et al. CPAP therapy of obstructive sleep apnea in Type 2 diabetics improves glycemic control during sleep. J. Clin. Sleep Med.4(6), 538–542 (2008).
   PubMed Web of Science ®Google Scholar
• Babu AR, Herdegen J, Fogelfeld L, Shott S, Mazzone T. Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. Arch. Intern. Med.165(4), 447–452 (2005).
   PubMed Web of Science ®Google Scholar
• Cuhadaroglu C, Utkusavas A, Ozturk L, Salman S, Ece T. Effects of nasal CPAP treatment on insulin resistance, lipid profile, and plasma leptin in sleep apnea. Lung187(2), 75–81 (2009).
   PubMed Web of Science ®Google Scholar
• Stamler J, Wentworth D, Neaton JD. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA256(20), 2823–2828 (1986).
   PubMed Web of Science ®Google Scholar
• Goff DC Jr, D’Agostino RB Jr, Haffner SM, Otvos JD. Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. Results from the Insulin Resistance Atherosclerosis Study. Metabolism54(2), 264–270 (2005).
   PubMed Web of Science ®Google Scholar
• Tan KC, Chow WS, Lam JC et al. HDL dysfunction in obstructive sleep apnea. Atherosclerosis184(2), 377–382 (2006).
   PubMed Web of Science ®Google Scholar
• Borgel J, Sanner BM, Bittlinsky A et al Obstructive sleep apnoea and its therapy influence high-density lipoprotein cholesterol serum levels. Eur. Respir. J.27(1), 121–127 (2006).
   PubMed Web of Science ®Google Scholar
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA285(19), 2486–2497 (2001).
   PubMed Web of Science ®Google Scholar
• Brown G, Albers JJ, Fisher LD et al. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N. Engl. J. Med.323(19), 1289–1298 (1990).
   PubMed Web of Science ®Google Scholar
• Lee PY, Yun AJ, Bazar KA. Acute coronary syndromes and heart failure may reflect maladaptations of trauma physiology that was shaped during pre-modern evolution. Med. Hypotheses62(6), 861–867 (2004).
   PubMed Web of Science ®Google Scholar
• Fletcher EC. Cardiovascular disease associated with obstructive sleep apnea. Monaldi Arch. Chest Dis.59(3), 254–261 (2003).
   PubMedGoogle Scholar
• Mansfield DR, Gollogly NC, Kaye DM, Richardson M, Bergin P, Naughton MT. Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am. J. Respir. Crit. Care Med.169(3), 361–366 (2004).
   PubMed Web of Science ®Google Scholar
• Milleron O, Pilliere R, Foucher A et al. Benefits of obstructive sleep apnoea treatment in coronary artery disease: a long-term follow-up study. Eur. Heart J.25(9), 728–734 (2004).
   PubMed Web of Science ®Google Scholar
• Sajkov D, Wang T, Saunders NA, Bune AJ, Neill AM, Douglas MR. Daytime pulmonary hemodynamics in patients with obstructive sleep apnea without lung disease. Am. J. Respir. Crit. Care Med.159(5 Pt 1), 1518–1526 (1999).
   PubMed Web of Science ®Google Scholar
• Harsch IA, Hahn EG, Konturek PC. Insulin resistance and other metabolic aspects of the obstructive sleep apnea syndrome. Med. Sci. Monit.11(3), RA70–RA75 (2005).
   PubMed Web of Science ®Google Scholar
• Eastwood PR, Malhotra A, Palmer LJ et al. Obstructive sleep apnoea: from pathogenesis to treatment: current controversies and future directions. Respirology15(4), 587–595 (2010).
   PubMed Web of Science ®Google Scholar
• Sanner M, Ko N, Oberauemr C, Thomaws EBS, Walzide KM. Sleep-disordered breathing in patients referred for angina evaluation – association with left ventricular dysfunction. Clin. Cardiol.24, 146–150 (2001).
   PubMed Web of Science ®Google Scholar
• Schäfer H, Koehler U, Ewig S, Hasper E, Tasci S, Lüderitz B. Obstructive sleep apnea as a risk marker in coronary artery disease. Cardiology92(2), 79–84 (1999).
   PubMed Web of Science ®Google Scholar
• Einhorn D, Stewart DA, Erman MK, Gordon N, Philis-Tsimikas A, Casal E. Prevalence of sleep apnea in a population of adults with Type 2 diabetes mellitus. Endocr. Pract.13(4), 355–362 (2007).
   PubMedGoogle Scholar
• Sjöström C, Lindberg E, Elmasry A, Hägg A, Svärdsudd K, Janson C. Prevalence of sleep apnoea and snoring in hypertensive men: a population based study. Thorax57(7), 602–607 (2002).
   PubMed Web of Science ®Google Scholar
• Gami AS, Pressman G, Caples SM et al. Association of atrial fibrillation and obstructive sleep apnea. Circulation110, 364–367 (2004).
   PubMed Web of Science ®Google Scholar
• Javaheri S, Storfer-Isser A, Rosen CL, Redline S. Sleep quality and elevated blood pressure in adolescents. Circulation118(10), 1034–1040 (2008).
   PubMed Web of Science ®Google Scholar
• Logan AG, Perlikowski SM, Mente A et al. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J. Hypertens.19(12), 2271–2277 (2001).
   PubMed Web of Science ®Google Scholar